Global Active Pharmaceutical Ingredient Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
- Published Date: 2021-04-23
- Report ID: 104390
- Pages: 128
-
Format:
Summary
World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war.
Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing global slowdown, which got aggravated due to the current Covid-19 crisis. The latter resulted in large scale disruptions in supply chains and demand resulting in cancellation of orders.
Prudent Markets analysis shows that as China started reopening its economy, world exports initially recovered across the board. But estimates of the expected recovery in 2021 are uncertain, with outcomes depending largely on the duration of the outbreak and the effectiveness of the policy responses.
This research report indicated that the global Active Pharmaceutical Ingredient market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. In terms of the export, China occupied more than XX % export market share in 2019, India occupied XX %. XXX is the second largest region around the world, it occupied about XX % export market share in 2019. In terms of the Local Capacity, XXX is the largest region around the world, it occupied about XX % export market share in 2019.
Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Active Pharmaceutical Ingredient Market by Prudent Markets Include
China
EU
North America
Japan
India
Southeast Asia
South America
Middle East and Africa
Competitive Analysis; Who are the Major Players in Active Pharmaceutical Ingredient Market
Teva
Novartis
Pfizer
Johnson & Johnson
Mylan
North China Pharmaceutical Group
Dr. Reddy's Laboratories
Roche
Aurobindo pharma
Sun Pharmaceutical Industries
Boehringer Ingelheim GmbH
Bayer
BASF
DSM
Zhejiang Medicine
Biocon
Johnson Matthey
Hisun Pharmacy
Cambrex
Shandong Xinhua Pharmaceutical
Lonza group
Huahai Pharmaceutical
Haerbin Pharmaceutical Group
Cipla
Tian Yao
Lupin
North East Pharmaceutical
Albemarle
Shandong Lukang Pharmaceutical
JiangsuHengrui Medicine
...
Major Type of Active Pharmaceutical Ingredient Covered in Prudent Markets report:
Synthetic API
Biotech API
Other
Application Segments Covered in Prudent Markets Market
Chemical
Deodorant
Dailylife
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Active Pharmaceutical Ingredient Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Synthetic API -Product Introduction and Major Manufacturers
1.1.2 Biotech API -Product Introduction and Major Manufacturers
1.1.3 Other -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market Analysis
2.1 China Active Pharmaceutical Ingredient Status and Prospect (2015-2026)
2.1.1 China Active Pharmaceutical Ingredient Market Size and Growth Rate (2015-2026)
2.1.2 China Active Pharmaceutical Ingredient Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.2 EU Active Pharmaceutical Ingredient Status and Prospect (2015-2026)
2.2.1 EU Active Pharmaceutical Ingredient Market Size and Growth Rate (2015-2026)
2.2.2 EU Active Pharmaceutical Ingredient Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.3 USA Active Pharmaceutical Ingredient Status and Prospect (2015-2026)
2.3.1 USA Active Pharmaceutical Ingredient Market Size and Growth Rate (2015-2026)
2.3.2 USA Active Pharmaceutical Ingredient Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.4 Japan Active Pharmaceutical Ingredient Status and Prospect (2015-2026)
2.4.1 Japan Active Pharmaceutical Ingredient Market Size and Growth Rate (2015-2026)
2.4.2 Japan Active Pharmaceutical Ingredient Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.5 India Active Pharmaceutical Ingredient Status and Prospect (2015-2026)
2.5.1 India Active Pharmaceutical Ingredient Market Size and Growth Rate (2015-2026)
2.5.2 India Active Pharmaceutical Ingredient Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.6 Southeast Asia Active Pharmaceutical Ingredient Status and Prospect (2015-2026)
2.6.1 Southeast Asia Active Pharmaceutical Ingredient Market Size and Growth Rate (2015-2026)
2.6.2 Southeast Asia Active Pharmaceutical Ingredient Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.7 South America Active Pharmaceutical Ingredient Status and Prospect (2015-2026)
2.7.1 South America Active Pharmaceutical Ingredient Market Size and Growth Rate (2015-2026)
2.7.2 South America Active Pharmaceutical Ingredient Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.8 Active Pharmaceutical Ingredient Status and Prospect (2015-2026)
2.8.1 Active Pharmaceutical Ingredient Market Size and Growth Rate (2015-2026)
2.8.2 Active Pharmaceutical Ingredient Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
3 Global Active Pharmaceutical Ingredient Market Assessment by Segment
3.1 Global Active Pharmaceutical Ingredient Capacity and Growth Rate
3.2 Global Active Pharmaceutical Ingredient Sales by Type
3.3 Global Active Pharmaceutical Ingredient Sales Revenue by Type
3.4 Global Active Pharmaceutical Ingredient Consumption by Application
4 Global Active Pharmaceutical Ingredient Market Assessment by Regions
4.1 Global Active Pharmaceutical Ingredient Production Analysis and Forecast by Regions (2015-2026)
4.2 Global Active Pharmaceutical Ingredient Sales Analysis and Forecast by Regions (2015-2026)
4.3 Global Active Pharmaceutical Ingredient Sales Revenue Analysis and Forecast by Regions (2015-2026)
5 Value Chain (Impact of COVID-19)
5.1 Active Pharmaceutical Ingredient Value Chain Analysis
5.1.1 Upstream
5.1.2 Downstream
5.2 COVID-19 Impact on Active Pharmaceutical Ingredient Industry
5.2.1 Industrial Policy Issued Under the Epidemic Situation
5.3 Cost-Under the Epidemic Situation
5.3.1 Cost of Raw Material
5.4 Channel Analysis
5.4.1 Distribution Channel-Under the Epidemic Situation
5.4.2 Distributors
6 Competitive Landscape
6.1 Global Active Pharmaceutical Ingredient Capacity Market Share of Manufacturers (2019-2020)
6.2 Global Active Pharmaceutical Ingredient Sales Market Share of Manufacturers (2019-2020)
6.3 Global Active Pharmaceutical Ingredient Sales Revenue Market Share of Manufacturers (2019-2020)
7 Active Pharmaceutical Ingredient Competitive Analysis
7.1 Teva
7.1.1 Teva Company Profiles
7.1.2 Teva Product Introduction
7.1.3 Teva Active Pharmaceutical Ingredient Production, Revenue (2015-2020)
7.1.4 SWOT Analysis
7.2 Novartis
7.2.1 Novartis Company Profiles
7.2.2 Novartis Product Introduction
7.2.3 Novartis Active Pharmaceutical Ingredient Production, Revenue (2015-2020)
7.2.4 SWOT Analysis
7.3 Pfizer
7.3.1 Pfizer Company Profiles
7.3.2 Pfizer Product Introduction
7.3.3 Pfizer Active Pharmaceutical Ingredient Production, Revenue (2015-2020)
7.3.4 SWOT Analysis
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Company Profiles
7.4.2 Johnson & Johnson Product Introduction
7.4.3 Johnson & Johnson Active Pharmaceutical Ingredient Production, Revenue (2015-2020)
7.4.4 SWOT Analysis
7.5 Mylan
7.5.1 Mylan Company Profiles
7.5.2 Mylan Product Introduction
7.5.3 Mylan Active Pharmaceutical Ingredient Production, Revenue (2015-2020)
7.5.4 SWOT Analysis
7.6 North China Pharmaceutical Group
7.6.1 North China Pharmaceutical Group Company Profiles
7.6.2 North China Pharmaceutical Group Product Introduction
7.6.3 North China Pharmaceutical Group Active Pharmaceutical Ingredient Production, Revenue (2015-2020)
7.6.4 SWOT Analysis
7.7 Dr. Reddy's Laboratories
7.7.1 Dr. Reddy's Laboratories Company Profiles
7.7.2 Dr. Reddy's Laboratories Product Introduction
7.7.3 Dr. Reddy's Laboratories Active Pharmaceutical Ingredient Production, Revenue (2015-2020)
7.7.4 SWOT Analysis
7.8 Roche
7.8.1 Roche Company Profiles
7.8.2 Roche Product Introduction
7.8.3 Roche Active Pharmaceutical Ingredient Production, Revenue (2015-2020)
7.8.4 SWOT Analysis
7.9 Aurobindo pharma
7.9.1 Aurobindo pharma Company Profiles
7.9.2 Aurobindo pharma Product Introduction
7.9.3 Aurobindo pharma Active Pharmaceutical Ingredient Production, Revenue (2015-2020)
7.9.4 SWOT Analysis
7.10 Sun Pharmaceutical Industries
7.10.1 Sun Pharmaceutical Industries Company Profiles
7.10.2 Sun Pharmaceutical Industries Product Introduction
7.10.3 Sun Pharmaceutical Industries Active Pharmaceutical Ingredient Production, Revenue (2015-2020)
7.10.4 SWOT Analysis
7.11 Boehringer Ingelheim GmbH
7.12 Bayer
7.13 BASF
7.14 DSM
7.15 Zhejiang Medicine
7.16 Biocon
7.17 Johnson Matthey
7.18 Hisun Pharmacy
7.19 Cambrex
7.20 Shandong Xinhua Pharmaceutical
7.21 Lonza group
7.22 Huahai Pharmaceutical
7.23 Haerbin Pharmaceutical Group
7.24 Cipla
7.25 Tian Yao
7.26 Lupin
7.27 North East Pharmaceutical
7.28 Albemarle
7.29 Shandong Lukang Pharmaceutical
7.30 JiangsuHengrui Medicine
8 Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
